Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
Abstract Schizophrenia is a widespread psychiatric disorder that affects 0.5–1.0% of the world’s population and induces significant, long-term disability that exacts high personal and societal